Explore

Trendline Trendline
Veradermics Announces Upsized Public Offering and Private Placement to Raise $414.4 Million

Veradermics Announces Upsized Public Offering and Private Placement to Raise $414.4 Million

Veradermics Announces Upsized Public Offering and Private Placement to Raise $414.4 Million
Trendline Trendline
Veradermics Announces $384.4 Million Upsized Public Offering and Private Placement

Veradermics Announces $384.4 Million Upsized Public Offering and Private Placement

Veradermics Announces $384.4 Million Upsized Public Offering and Private Placement
Trendline Trendline
Wescan Goldfields Inc. Announces $2.5 Million Private Placement for Drilling Program

Wescan Goldfields Inc. Announces $2.5 Million Private Placement for Drilling Program

Wescan Goldfields Inc. Announces $2.5 Million Private Placement for Drilling Program
Trendline Trendline
DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update

DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update

DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update
Trendline Trendline
Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call

Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call

Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call
Trendline Trendline
Agilent Technologies to Release Q2 Fiscal Year 2026 Financial Results on May 27

Agilent Technologies to Release Q2 Fiscal Year 2026 Financial Results on May 27

Agilent Technologies to Release Q2 Fiscal Year 2026 Financial Results on May 27
Trendline Trendline
Sapient Unveils Tumor Protein Mapping Platform to Enhance Cancer Drug Development

Sapient Unveils Tumor Protein Mapping Platform to Enhance Cancer Drug Development

Sapient Unveils Tumor Protein Mapping Platform to Enhance Cancer Drug Development
Trendline Trendline
Robinhood Reports 15% Revenue Growth in Q1-2026 Amid Crypto Revenue Decline

Robinhood Reports 15% Revenue Growth in Q1-2026 Amid Crypto Revenue Decline

Robinhood Reports 15% Revenue Growth in Q1-2026 Amid Crypto Revenue Decline
Trendline Trendline
Veradermics Initiates Public Offering to Expand Dermatology Innovations

Veradermics Initiates Public Offering to Expand Dermatology Innovations

Veradermics Initiates Public Offering to Expand Dermatology Innovations
Trendline Trendline
Veradermics Announces Successful Late-Stage Trial for Hair Loss Drug VDPHL01

Veradermics Announces Successful Late-Stage Trial for Hair Loss Drug VDPHL01

Veradermics Announces Successful Late-Stage Trial for Hair Loss Drug VDPHL01
Trendline Trendline
Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community

Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community

Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community
Trendline Trendline
Travere Therapeutics to Announce Q1 2026 Financial Results, Hosts Conference Call

Travere Therapeutics to Announce Q1 2026 Financial Results, Hosts Conference Call

Travere Therapeutics to Announce Q1 2026 Financial Results, Hosts Conference Call